Why the study?
What are the sex-specific differences in hemodialysis prevalence, practices, and mortality rates in patients with end-stage renal disease?
What are the sex-specific differences in hemodialysis prevalence, practices, and mortality rates in patients with end-stage renal disease?
Women with end-stage renal disease on hemodialysis have a diminished survival advantage compared to men, alongside lower treatment prevalence and differences in modifiable practices like catheter use.
Women may face undertreatment and reduced survival on hemodialysis; leaves open whether addressing sex disparities improves ESRD outcomes.
Women's survival advantage was markedly diminished in hemodialysis patients. The finding that fewer women than men were being treated with dialysis for end-stage renal disease merits detailed further study, as the large discrepancies in sex-specific hemodialysis prevalence by country and age group are likely explained by factors beyond biology. Modifiable variables, such as catheter use, showing significant sex interactions suggest interventional targeting. Please see later in the article for the Editors' Summary.
No takes yet. Share an insight, caveat, or question.
Hecking et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: